@article{JTD25919,
author = {Yousheng Mao and Zhentao Yu and Bin You and Wentao Fang and Brian Badgwell and Mark F. Berry and DuyKhanh P. Ceppa and Chun Chen and Haiquan Chen and Miguel A. Cuesta and Xavier Benoit D’Journo and Guy D. Eslick and Jianhua Fu and Xiangning Fu and Shugeng Gao and Jianxing He and Jie He and Yunchao Huang and Gening Jiang and Zhongmin Jiang and Jae Y. Kim and Danqing Li and Hui Li and Shanqing Li and Deruo Liu and Lunxu Liu and Yongyu Liu and Xiaofei Li and Yin Li and Weimin Mao and Daniela Molena and Christopher R. Morse and Nuria M. Novoa and Lijie Tan and Qunyou Tan and Alper Toker and Ti Tong and Qun Wang and Benny Weksler and Lin Xu and Shidong Xu and Tiansheng Yan and Lanjun Zhang and Xingyi Zhang and Xun Zhang and Zhu Zhang and Xiuyi Zhi and Qinghua Zhou},
title = {Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {1},
year = {2018},
keywords = {},
abstract = {Esophageal cancer (EC) is a highly prevalent malignancy in China. According to the data released by National Cancer Registry Center of China in 2015, the prevalence of EC was 21.17/100,000 in China in 2012, ranking fifth among all malignancies; the mortality rate was 15.58/100,000, ranking fourth. It is expected that there will be 477,900 new EC cases nationwide in 2015, whereas 375,000 people will die from EC (1,2). Worldwide, EC is the 8th most common malignancy, with 416,000 new cases in 2012 (3). At present, EC treatment is based on multidisciplinary treatment, but surgery remains the most effective therapy in optimizing long-term prognosis in patients without metastatic disease. The ideal surgical approach is a matter of debate.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/25919}
}